1477-68-5
基本信息
甲氧酩胺盐酸盐
3-甲氧基色胺
甲基多巴胺盐酸盐
3-甲氧基色胺盐酸盐
3-甲氧基酪胺盐酸盐
3-O-甲基多巴胺盐酸盐
3-甲氧基-4-羟基苯乙胺
甲醇中甲氧酩胺溶液标准物质
3-甲氧基色胺盐酸盐 1ML
3-METHOXYTYRAMINE
RARECHEM AL BW 0216
TIMTEC-BB SBB000426
TIMTEC-BB SBB003882
2-ethyl-d4-aMine HCl
3-METHOXYTYRAMINE HCL
3-O-Methyldopamine HCL
MethoxytyraMine solution
3-Methoxy-p-tyraMine HCl
物理化学性质
熔点 | 213-215 °C(lit.) |
闪点 | 9℃ |
储存条件 | −20°C |
溶解度 | 可溶于DMSO(轻微)、甲醇(轻微、超声处理)、水(轻微) |
形态 | crystalline |
颜色 | white to light brown |
BRN | 3631283 |
稳定性 | 稳定,但可能对光敏感。易燃。与强氧化剂不相容。 |
安全数据
危险性符号(GHS) | GHS02,GHS06,GHS08 |
警示词 | 危险 |
危险性描述 | H225-H301+H311+H331-H370 |
防范说明 | P210-P280-P301+P310+P330-P302+P352+P312-P304+P340+P311 |
危险品标志 | Xi |
危险类别码 | 36/37/38 |
安全说明 | 26-36-37/39 |
危险品运输编号 | UN1230 - class 3 - PG 2 - Methanol, solution |
WGK Germany | 3 |
F | 3-10 |
危险等级 | IRRITANT |
海关编码 | 29222990 |
制备方法
上下游产品信息
图谱信息
2-甲氧基-4-(2-氨基乙基)苯酚(1477-68-5)质谱(MS)2-甲氧基-4-(2-氨基乙基)苯酚(1477-68-5)核磁图(1HNMR)2-甲氧基-4-(2-氨基乙基)苯酚(1477-68-5)红外图谱(IR1)2-甲氧基-4-(2-氨基乙基)苯酚(1477-68-5)Raman光谱2-甲氧基-4-(2-氨基乙基)苯酚价格(试剂级)
报价日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
2024/11/08 | 17285 | 2-甲氧基-4-(2-氨基乙基)苯酚 3-O-Methyldopamine hydrochloride, 99+%, Thermo Scientific Chemicals | 1477-68-5 | 100mg | 958元 |
2024/11/08 | 17285 | 2-甲氧基-4-(2-氨基乙基)苯酚 3-O-Methyldopamine hydrochloride, 99+%, Thermo Scientific Chemicals | 1477-68-5 | 1g | 4577元 |
2024/11/08 | HY-103638A | 2-甲氧基-4-(2-氨基乙基)苯酚 3-Methoxytyramine | 1477-68-5 | 100mg | 500元 |
常见问题列表
Human Endogenous Metabolite
|
The intensity of the fluorescence developed is in a linear relation to the amount of 3-Methoxytyramine hydrochloride presented in the sample up to at least 1 μg. When a high concentration of dopamine is present in the reaction mixture, there is some reduction in the fluorescence derived from 3-Methoxytyramine hydrochloride.
The extracellular DA metabolite 3-Methoxytyramine hydrochloride (3-MT) induces significant behavioral activation in DDD mice. This activity however, is mostly presented as a set of disorganized abnormal movements that includes tremor, head bobbing, straub tail, grooming and abnormal orofacial movements rather than normal forward activity. No effect is observed when 3-Methoxytyramine hydrochloride is infused at doses below 9 µg, at 9 µg and higher doses 3-Methoxytyramine hydrochloride dose-dependently causes transient behavioral activation with a complex set of behaviors. In particular, transient hyperactivity and stereotypy, sniffing, grooming, rearing and mild abnormal involuntary movements (AIMs) at the level of limbs is observed after infusion of 9 µg of 3-Methoxytyramine hydrochloride. Similar behaviors are also observed after 18 µg of 3-Methoxytyramine hydrochloride with the additional appearance of tremor as well as oral and whole body AIMs.